Human papillomaviruses have been implicated in many cutaneous diseases. Practicing dermatopathologists often consider using immunohistochemistry and in situ hybridization to help clarify the histologic diagnosis, particularly in cases with borderline or nondiagnostic features. We reviewed the current evidence behind the use of these two techniques in dermatopathology.We identified only two studies utilizing the currently available immunohistochemical antibodies. We found more evidence regarding the use of in situ hybridization; however, the majority of this evidence focuses on diagnosing condylomas and other lesions of the genital skin. We also assessed current utilization patterns of attendees of the American Society of Dermatopathology annual meeting (Chicago, 2016) which revealed a wide spectrum of current utilization ranging from no use to regular use more than once per month. Two-thirds of respondents utilized these tests primarily when requested by the submitting clinician and one-third of the respondents utilize these tests reflexively in specific clinical scenarios. The AUC Task Force chose to evaluate the use of HPV ISH and IHC in dermatopathology. We chose these tests because they are often used by dermatopathologists and also requested by our clinical colleagues. In addition, we felt that there was a broad spectrum of current utilization of these tests ranging from dermatopathologists who never or rarely perform these studies to labs that routinely order them in specific situations.HPV are double-stranded, nonenveloped deoxyribonucleic acid (DNA) viruses of the papovirus family. Over 100 subtypes have been described to date. These viruses have been implicated in many cutaneous diseases including: verruca, condyloma, verrucous carcinoma, squamous cell carcinoma (SCC) and squamous cell carcinoma in situ (SCCIS) of the nail unit, SCC/SCCIS of the genital skin and SCC/SCCIS in immunocompromised patients.With respect to HPV ISH, many commercially available typespecific probes and "cocktails" are available; however, type-specific probes for HPV 6,11,16,18,31 and